United States · FDA National Drug Code directory
SIVEXTRO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67919-041_340a4655-ccf2-4c0f-a305-7576c06f4518
- Product NDC
- 67919-041
- Form
- TABLET, FILM COATED
- Composition / generic term
- tedizolid phosphate
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140620
- Source listing expiry
- 20271231
Source-listed ingredients
- TEDIZOLID PHOSPHATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (67919-041-04) · 67919-041-04
- 1 BLISTER PACK in 1 CARTON (67919-041-05) / 6 TABLET, FILM COATED in 1 BLISTER PACK · 67919-041-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →